2 completed, 1 not yet recruiting, 1 suspended, 1 terminated. 2 Early Phase 1, 2 Phase 4, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Terminated 1, Withdrawn 1 |
| Phase 4 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Suspended 1 |
Follow PO Placebo: new trials by email Literature Review of PO Placebo trials Research Report on PO Placebo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Pain Improvement for Intravenous Versus Oral Acetaminophen in Acute Pelvic Pain Acetaminophen 1000mg PO, IV Acetaminophen 1000mg, IV Placebo - Pelvic Pain | Phase 4 | Not yet recruiting | Montefiore Medical Center | 140 | 2026-11-01 | 2026-09-23 |
| Theophylline for Depression Study Theophylline ER, PO placebo, Lipopolysaccharide (LPS) - Depression | Early Phase 1 | Withdrawn | University of California, Los Angeles | 2023-03-01 | 2021-11-05 | |
| Pharmacokinetics and Safety of 'CG-745 IV' and 'CG-750' in Healthy Male Adults CG-745 IV Solution, CG-750 125mg capsule, PO Placebo - Healthy | Phase 1 | Completed | CrystalGenomics, Inc. | 24 | 2019-12-16 | 2022-04-26 |
| Intravenous Ketamine for Pain Control During First Trimester Surgical Abortion PO Morphine, IV Fentanyl, IV Ketamine - Abortion in First Trimester | Phase 3 | Suspended | Dr. Marie Eve Sophie Bussiere-Cote | 123 | 2019-06-10 | 2022-09-08 |
| Leucine for Depression Study (L-DEP) leucine, PO placebo, lipopolysaccharide (LPS) - Depression | Early Phase 1 | Terminated | University of California, Los Angeles | 59 | 2018-09-01 | 2023-06-08 |
| Preoperative IV Versus Oral Acetaminophen IV Acetaminophen, PO Acetaminophen, PO Placebo - Pain, Postoperative | Phase 4 | Completed | TriHealth Inc. | 120 | 2018-04-01 | 2019-05-14 |
Depression (2) · Pain, Postoperative (1) · Pelvic Pain (1)
University of California, Los Angeles (2) · CrystalGenomics, Inc. (1) · Dr. Marie Eve Sophie Bussiere-Cote (1) · Montefiore Medical Center (1) · TriHealth Inc. (1)
United States (4) · Canada (1) · South Korea (1)
Ashley Waddington, MD, MPA (1) · Eddie M Irizarry, MD (1) · Joshua H Cho, MD, PhD (1) · SeungHwan Lee, Ph.D (1) · Sophie Bussiere-Cote, MD (1)
2025 (1), R21MH113915 (1)